PCA
BHVN icon

Pallas Capital Advisors’s Biohaven BHVN Stock Holding History

Pallas Capital Advisors’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$353K Buy
23,712
+7,004
+42% +$75.4K 0.01% 684
2026
Q1 		$141K Buy
16,708
+1,321
+9% +$14.5K 0.01% 786
2025
Q4 		$174K Buy
+15,387
New +$191K 0.01% 823

Other funds holding BHVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pallas Capital Advisors's BHVN Position: Q2 2026 in Review

Pallas Capital Advisors increased its Biohaven (BHVN) stake by 42% in Q2 2026, buying an estimated $75.4K and bringing the position to 23,712 shares worth $353K. The position accounts for 0.01% of the portfolio, ranked #684.

Pallas Capital Advisors first reported a position in BHVN in Q4 2025 and has held it in 3 quarters since. 292 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • Pallas Capital Advisors held 23,712 shares of Biohaven worth $353K as of Q2 2026.
  • Pallas Capital Advisors bought 7,004 Biohaven shares in Q2 2026, an estimated $75.4K.
  • Biohaven made up 0.01% of Pallas Capital Advisors's portfolio in Q2 2026, its #684 holding.
  • Pallas Capital Advisors first reported a position in Biohaven in Q4 2025 and has held it in 3 quarters since.
  • 292 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Pallas Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.